Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Scott Ribich News

Scott Ribich News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scott Ribich. Real-time updates on events, politics, business and more.

Ipsen : adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3 -Today at 10:52 am

August 30, 2023
Ipsen adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3 ...
United States Oumin Shi P Ann Boriack Sjodin Zacharya Gurard Levin Scott Ribich Ipsen Euronext
Source: marketscreener.com

Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3

October 18, 2021
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor program Building on recent announcements, this collaboration with Accent
France General Qi Wang United States Wei Wang Yin Dong United Kingdom
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science